Marrow transplantation, cost effectiveness analysis and setting limits.
Marrow transplantation is currently second only to kidney in major organ transplants performed in the United States. Like other forms of transplantation, marrow transplantation is expensive. Unlike other forms of transplantation, however, marrow transplantation is not particularly constrained by a limited supply of donor organs. High costs combined with the potential for substantial growth make difficult resource choices inevitable.